Zentiva, Sanofi’s Generic Arm to be Sold for $2.4B

Like
Like Love Haha Wow Sad Angry

Zentiva, Sanofi’s Generic Arm to be Sold for $2.4B The French healthcare firm is now reportedly in talks to sell off its generic medicine wing for an estimated 1.9 billion euros ($2.4 billion) in order to bring its biotech back in focus. It is pitching its copycat drug unit Zentiva to Advent International, the companies acknowledged […]

The post Zentiva, Sanofi’s Generic Arm to be Sold for $2.4B appeared first on BioTecNika .Read more at www.biotecnika.org/2018/04/zentiva-sanofis-generic-arm-to-be-sold-for-2-4b/

Like
Like Love Haha Wow Sad Angry

Related posts